CAT Catco Reinsurance Opportunities Fund Limited

24.00

0.00 (0.00%)

16 Aug 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Catco Reinsurance Opportunities Fund Limited	LSE:CAT	London	Ordinary Share	BMG1961Q3242	ORD USD0.00013716 (DI)

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	24.00	13.00	35.00	24.00	24.00	24.00	0.00	01:00:00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Unit Inv Tr, Closed-end Mgmt	6.33M	5.44M	3.6440	6.59	35.84M

Cambridge Antibody - Re Staff Share Scheme

22/12/1997 12:42pm

UK Regulatory

RNS No 9853n
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP
22nd December 1997


On December 19 1997 the Company issued an additional 14,982 10p ordinary
shares (approximately 0.07% of the existing shareholding) to its wholly owned
subsidiary CAT Group Employees' Trustees Limited the Corporate Trustee of   an
Inland Revenue approved Staff Share Scheme. The Corporate Trustee will hold
the shares for the benefit of the eligible employees pursuant to the terms  of
the Scheme. The Directors of CAT Group Employees' Trustee Limited are John
Aston Peter Garland and Sir Aaron Klug all of whom are also directors of
Cambridge Antibody Technology plc. A separate announcement has been made today
regarding the shareholding of Executive Directors as a result of operation of
the Scheme.


END

MSCNFAAAAAXXFFN